Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma. (scientific article published on 6 April 2017)

Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors

Q24600405

The Bcl-2 apoptotic switch in cancer development and therapy

Q24620437

Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond

Q28199137

An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7

Q28199789

Validating survivin as a cancer therapeutic target

Q28201382

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Q28266682

Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling

Q28594767

Nuclear or cytoplasmic expression of survivin: what is the significance?

Q28748709

Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis

Q33182439

Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters

Q33809987

Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice

Q33982420

A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma

Q33997195

Prognostic relevance of molecular markers of oral cancer--a review

Q35136349

Survivin, versatile modulation of cell division and apoptosis in cancer

Q35591693

G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma

Q35740098

Control of apoptosis during angiogenesis by survivin expression in endothelial cells

Q35745355

Survival analysis of 5595 head and neck cancers--results of conventional treatment in a high-risk population

Q36292503

Prognostic importance of survivin in breast cancer

Q36646800

Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma

Q36647832

Nuclear survivin as a biomarker for non-small-cell lung cancer

Q36695441

Global epidemiology of oral and oropharyngeal cancer

Q37274268

High Vimentin Expression Associated with Lymph Node Metastasis and Predicated a Poor Prognosis in Oral Squamous Cell Carcinoma

Q37501207

Exploring the role of post-translational modifications on protein-protein interactions with survivin

Q38128480

Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma.

Q38456501

Survivin expression in the stomach: implications for mucosal integrity and protection

Q38520401

Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma

Q39155202

Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC).

Q39221176

Liaisons between survivin and Plk1 during cell division and cell death

Q39709805

Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma

Q39755799

Phosphorylation by aurora-B negatively regulates survivin function during mitosis.

Q40141531

Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment

Q40759643

The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma

Q43816032

Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function

Q43893446

Survivin expression in human osteosarcoma is a marker for survival

Q44414136

Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients

Q44559861

N-acetyl cysteine protects human oral keratinocytes from Bis-GMA-induced apoptosis and cell cycle arrest by inhibiting reactive oxygen species-mediated mitochondrial dysfunction and the PI3K/Akt pathway

Q46673698

Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

Q53333739

Differential subcellular localization of functionally divergent survivin splice variants.

Q53384616

Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma.

Q53465124

Oral Cancer

Q56603649

Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis

Q64377539

Surgical treatment outcomes of localized squamous carcinoma of buccal mucosa

Q80610191

Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer

Q80945456

Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma

issue

number of pages

page(s)

894-902

P577

publication date

2017-04-06

P1433

published in

Cell Cycle

Q1254166

P1476

title

Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma.

P478

volume

Reverse relations

cites work (P2860)

Q89315727	EGFR activation induced Snail-dependent EMT and myc-dependent PD-L1 in human salivary adenoid cystic carcinoma cells
Q99419149	EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy
Q58772889	Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma
Q57764673	Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma